Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

The SAMP8 Mouse: A Model to Develop Therapeutic Interventions for Alzheimers Disease

Author(s): John E. Morley, Susan A. Farr, Vijaya B. Kumar and Harvey J. Armbrecht

Volume 18, Issue 8, 2012

Page: [1123 - 1130] Pages: 8

DOI: 10.2174/138161212799315795

Abstract

The senescence accelerate mouse P8 (SAMP8) is an excellent model of early learning and memory problems. A number of studies have shown that it has cholinergic deficits, oxidative damage, alterations in membrane lipids and circadian rhythm disturbances. The brains of the SAMP8 overproduce amyloid precursor protein (APP), amyloid-beta protein and have an increased physphorylation of tau. An antisense to APP has been developed that reverses the cognitive deficits and oxidative damage. This antisense represents a poten-tial treatment for Alzheimers disease.

Keywords: Antisense, amyloid-beta, SAMP8, oxidative damage, Alzheimer's, blood brain barrier, testosterone, amyloid precursor protein (APP), cognitive deficits


© 2024 Bentham Science Publishers | Privacy Policy